{"id":916123,"date":"2025-12-04T07:03:31","date_gmt":"2025-12-04T12:03:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/"},"modified":"2025-12-04T07:03:31","modified_gmt":"2025-12-04T12:03:31","slug":"insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/","title":{"rendered":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>New 100 mg\/dL Target Glucose setting offers more customization and tighter glucose management.<\/i><\/li>\n<li><i>Enhanced algorithm helps users remain in Automated Mode to improve the user experience.<\/i><\/li>\n<li><i>Most requested new features enable healthcare providers to more effectively modify diabetes therapy to meet needs of people with diabetes.<\/i><\/li>\n<\/ul>\n<p>ACTON, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nInsulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.omnipod.com%2F&amp;esheet=54368766&amp;newsitemid=20251204178236&amp;lan=en-US&amp;anchor=tubeless+insulin+pump&amp;index=1&amp;md5=618ec1e09b5f32bba0f306ccfbce6bf4\">tubeless insulin pump<\/a> technology with its Omnipod\u00ae brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark in tubeless diabetes technology by offering a lower 100 mg\/dL Target Glucose option and a more seamless automated experience.\n<\/p>\n<p>\n\u201cThis is the most significant algorithm advancement to our Omnipod 5 System since its launch in 2022,\u201d said Eric Benjamin, Insulet Executive Vice President and Chief Operating Officer. \u201cThese new features address the two most requested enhancements and reflect our relentless commitment to delivering meaningful innovation for those living with diabetes and the healthcare providers who support them. Every improvement we make is designed to strengthen clinical outcomes while making the Pod experience simpler, more personalized, and so seamless it disappears into everyday life.\u201d\n<\/p>\n<p><b>More Flexibility with a Lower Target Glucose Setting<\/b><\/p>\n<p>\nThe new 100 mg\/dL Target Glucose expands Omnipod 5\u2019s customization range to six settings between 100-150 mg\/dL in 10 mg\/dL increments. This flexibility allows healthcare providers to tailor insulin delivery more precisely, supporting individuals seeking tighter glucose management or those striving to meet specific glucose goals. It also directly impacts automated insulin delivery and improves the algorithm\u2019s responsiveness. Real world evidence has shown that lowering the glucose target is associated with increased time in range, with no clinically meaningful change in Time Below Range<sup>1 <\/sup>(TBR).\n<\/p>\n<p><b>Designed with Patients and HCPs in Mind<\/b><\/p>\n<p>\nIn addition, the upgraded Omnipod 5 algorithm helps users stay in Automated Mode with fewer interruptions, even during prolonged high glucose events. These advancements are designed to deliver strong clinical results with increased flexibility and greater ease of use, with fewer interruptions to daily life.\n<\/p>\n<p>\n\u201cThese enhancements to the Omnipod 5 algorithm are a meaningful step forward. As a clinician, it\u2019s exciting to offer patients a system that not only supports strong clinical outcomes but also builds their confidence in managing diabetes daily. More target glucose options and fewer interruptions mean a better experience for people with diabetes and their families,\u201d said Dr. Anita Swamy, MD, Pediatric Endocrinologist and Medical Director of the Chicago Children\u2019s Diabetes Center.\n<\/p>\n<p>\nThe updates to the Omnipod 5 algorithm are anticipated to launch in the United States in the first half of 2026, where Omnipod 5 is cleared for people aged 2 and older with type 1 and aged 18 and older with type 2 diabetes.\n<\/p>\n<p><i><sup>1<\/sup> Forlenza G, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. Real-world data from 403 people with type 1 diabetes aged 2+ using the Omnipod 5 System who transitioned from the (150 mg\/dL or 8.3 mmol\/L) to (110 mg\/dL or 6.1 mmol\/L) Target Glucose. Each Target Glucose was used for a consecutive period of 14-90 days. Median time in Range (70-180 mg\/dL) (3.8-10 mmol\/l) improved 11.8% (p&lt;0.05). Median time (&lt;70 mg\/dL or &lt;3.8 mmol\/l) +0.23% (p&lt;0.05). Real-world data from 58 people with type 2 diabetes (T2D) aged 18+ using the Omnipod 5 System who transitioned from 150 mg\/dL to 110 mg\/dL Target Glucose. Each Target Glucose was used for a consecutive period of 14-90 days. Median time in Range (70-180 mg\/dL) improved 10.4% (p&lt;0.05). Median time &lt; 70 mg\/dL +0.04% (non-significant). Omnipod 5 results based on users with \u226575% of days with \u2265220 readings available. Data on File. RF-042025-00013<\/i><\/p>\n<p><b>About Insulet Corporation:<\/b><\/p>\n<p>\nInsulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet\u2019s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, visit Insulet.com or omnipod.com.\n<\/p>\n<p>\n\u00a92025 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved. All other trademarks are the property of their respective owners.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251204178236\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251204178236\/en\/<\/a><\/span><\/p>\n<p><b><i>Investor Relations:<br \/>\n<\/i><\/b><br \/>Clare Trachtman<br \/>\n<br \/>Vice President, Investor Relations<br \/>\n<br \/>(978) 218-0889<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ctrachtman@insulet.com\">ctrachtman@insulet.com<br \/>\n<\/a><\/p>\n<p><b><i>Media:<br \/>\n<\/i><\/b><br \/>Angela Geryak Wiczek<br \/>\n<br \/>Senior Director, Corporate Communications<br \/>\n<br \/>(978) 932-0611<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:awiczek@insulet.com\">awiczek@insulet.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Devices Medical Supplies FDA Diabetes Clinical Trials Health Technology Biotechnology Health General Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251204178236\/en\/1711909\/3\/INSULET_Logo_RGB_No_tag.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience New 100 mg\/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested new features enable healthcare providers to more effectively modify diabetes therapy to meet needs of people with diabetes. ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-916123","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience New 100 mg\/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested new features enable healthcare providers to more effectively modify diabetes therapy to meet needs of people with diabetes. ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark &hellip; Continue reading &quot;Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-04T12:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience\",\"datePublished\":\"2025-12-04T12:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/\"},\"wordCount\":876,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/\",\"name\":\"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-12-04T12:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/","og_locale":"en_US","og_type":"article","og_title":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Market Newsdesk","og_description":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience New 100 mg\/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested new features enable healthcare providers to more effectively modify diabetes therapy to meet needs of people with diabetes. ACTON, Mass.&#8211;(BUSINESS WIRE)&#8211; Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod\u00ae brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark &hellip; Continue reading \"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-04T12:03:31+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience","datePublished":"2025-12-04T12:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/"},"wordCount":876,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/","name":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-12-04T12:03:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251204178236r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/insulet-announces-fda-510k-clearance-of-omnipod-5-algorithm-enhancements-that-redefine-insulin-delivery-and-simplify-the-pod-experience\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Insulet Announces FDA 510(k) Clearance of Omnipod\u00ae 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/916123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=916123"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/916123\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=916123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=916123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=916123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}